Novel siRNA-Based Therapies for Cancer

Time: 2:00 pm
day: Track B Day 1 AM


  • Development and proof-of-concept studies validating the potential of siRNA for tumor targeting
  • Application of a novel RNAi-based checkpoint inhibitor for the treatment of pancreatic cancer
  • Potential of RNAi-based cancer therapy: A longer-term look at the future of RNAi for the treatment of cancer